Compared to non-users, prevalent users of metformin and DPP4is experienced a slower cognitive decline with time. Secondly, compared to DPP4is, the use of insulin and sulfonylureas was associated with larger point-wise decrements in MMSE with annual intervals. This evidence concerns the gene INS and Mental deterioration.